News

2017 Feb 23

New Type of Genetic Mutation Identified in Cancer

A newly discovered type of genetic mutation that occurs frequently in cancer cells may provide clues about the disease’s origins and offer new therapeutic targets, according to new research from Weill Cornell Medicine and... Read more

2017 Feb 23

Weill Cornell expert, "General Hospital" actress unite to raise PV awareness

Finola Hughes from TV's "General Hospital" and Ellen K. Ritchie, M.D. are teaming up to raise awareness for myeloproliferative disorder polycythemia vera. Read more

2017 Feb 23

New type of genetic mutation identified in cancer

A study by Marcin Imielinski, M.D., Ph.D., illuminates a possible new type of driver of cancer: small (one-50 letter) insertions or deletions of DNA sequence, also called “indels,” in regions of the genome that do not code for proteins. Read more

2017 Feb 22

The RNA code comes into focus

Feature about epitranscriptomics highlights the work of Chris Mason and Samie Jaffrey. Read more

2017 Feb 17

Lobectomy in early NSCLC: Time to wrap up its storyline?

Nasser Altorki, M.D. weighs in on the role of lobectomy in early-stage non-small cell lung cancer. Read more

2017 Feb 17

Contributing to an international cancer corps

A team of radiologists, oncologists, surgeons and other physicians are partnering with the International Cancer Expert Corps (ICEC) to create a Weill Cornell Medicine hub of global outreach for cancer care. Read more

2017 Feb 15

New score predicts liver cancer after transplant

The MORAL score for hepatocellular carcinoma is highly predictive of recurrence-free survival and can accurately identify patients who should not undergo liver transplant with a living donor, according to Karim J. Halazun, M.D. Read more

Cold comfort: Carolyn Dempsey wore the DigniCap during chemotherapy. Photo provided by Carolyn Dempsey

2017 Feb 14

Scalp cooling can help some breast cancer patients retain hair

Scalp cooling can lessen some chemotherapy-induced hair loss – one of the most devastating hallmarks of cancer – in certain breast cancer patients, according to a new study from UC San Francisco, Weill Cornell Medicine and three other medical centers. Read more

Photo of Christopher Barbieri, M.D., Ph.D.

2017 Feb 10

We Are Weill Cornell Medicine: Dr. Christopher Barbieri

Christopher Barbieri, M.D., Ph.D., is a featured faculty member in the #WeAreWCM campaign. Read more

2017 Feb 09

Collaboration Employs New Strategies to Study the Spread of Cancer

Video of If cancer didn’t metastasize, or spread, it would be easy to cure, says Dr. Lewis Cantley , the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine. “We could merely cut it out, and... Read more

2017 Feb 09

Collaboration employs new strategies to study the spread of cancer

Feature about the new Center on the Physics of Cancer Metabolism collaboration between Ithaca and NYC. Read more

2017 Feb 09

Weill Cornell Medicine scientists seek to improve ovarian cancer therapies

Juan Cubillos-Ruiz and colleagues have been awarded a grant to define the role of a potentially crucial biomarker in the treatment of ovarian cancer tumors. Read more

2017 Feb 08

Medical Marvels: Life-saving treatment for chronic leukemia

Richard Furman, M.D. and patient Robert Frank Azopardi were recently featured on the abc7NY Medical Marvels series. Read more

2017 Feb 06

Old drug may provide new hope to melanoma patients

Diabetes drug phenformin shows promise as a treatment for melanoma, according to research from Lewis Cantley, Ph.D., and Jonathan Zippin, M.D., Ph.D. Read more

2017 Feb 02

Expert discusses upcoming agents to treat follicular lymphoma

John Leonard, M.D. discusses advancements in the treatment of follicular lymphoma. Read more

2017 Feb 01

Artificial Intelligence helps identify effective cancer drug combinations

Artificial intelligence (AI) can help scientists predict what combinations of already existing drugs may work in different types of cancer, according to two new studies from the lab of Olivier Elemento, Ph.D. Read more

2017 Jan 31

Grad student honored for teaching, cancer patient program

Peter DelNero, a doctoral candidate in biomedical engineering who works in the lab of Cornell University associate Claudia Fischbach-Teschl, Ph.D, has received the 2017 K. Patricia Cross Future Leaders Award. DelNero is one of eight graduate students nationwide to receive this prestigious award out of more than 250 nominees from 127 institutions. Read more

2017 Jan 30

News

New Type of Genetic Mutation Identified in Cancer

Weill Cornell expert, "General Hospital" actress unite to raise PV awareness

New type of genetic mutation identified in cancer

The RNA code comes into focus

Lobectomy in early NSCLC: Time to wrap up its storyline?

Contributing to an international cancer corps

New score predicts liver cancer after transplant

Scalp cooling can help some breast cancer patients retain hair

We Are Weill Cornell Medicine: Dr. Christopher Barbieri

Collaboration Employs New Strategies to Study the Spread of Cancer

Collaboration employs new strategies to study the spread of cancer

Weill Cornell Medicine scientists seek to improve ovarian cancer therapies

Medical Marvels: Life-saving treatment for chronic leukemia

Old drug may provide new hope to melanoma patients

Expert discusses upcoming agents to treat follicular lymphoma

Artificial Intelligence helps identify effective cancer drug combinations

Grad student honored for teaching, cancer patient program

Martin discusses ibrutinib-palbociclib combo in mantle cell lymphoma

Jaffrey wins Abel Award

Cantley elected as board chair of Hope Funds

Follow us on X

2022 Annual Report

2021 Annual Report

2018 Annual Report

2017 Annual Report

2016 Annual Report

Newsletters